TSH Trajectories During Levothyroxine Treatment in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Cohort

被引:1
作者
Ettleson, Matthew D. [1 ]
Penna, Gustavo C. E. [1 ]
Wan, Wen [2 ]
Bensenor, Isabela M. [3 ]
Laiteerapong, Neda [2 ]
Bianco, Antonio C. [1 ]
机构
[1] Univ Chicago, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA
[2] Univ Chicago, Sect Gen Internal Med, Chicago, IL 60637 USA
[3] Univ Sao Paulo, Clin Hosp, Ctr Clin & Epidemiol Res, Dept Med, BR-05508000 Sao Paulo, Brazil
基金
美国国家卫生研究院; 巴西圣保罗研究基金会;
关键词
hypothyroidism; levothyroxine; longitudinal analysis; cardiovascular outcomes; THYROID-STIMULATING HORMONE; BLOOD-PRESSURE; REFERENCE RANGE; UNDER-TREATMENT; UNITED-STATES; SERUM TSH; ASSOCIATION; HYPOTHYROIDISM; POPULATION; REPLACEMENT;
D O I
10.1210/clinem/dgae294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Thyroid-stimulating hormone (TSH) trajectory classification represents a novel approach to defining the adequacy of levothyroxine (LT4) treatment for hypothyroidism over time. Objective: This is a proof of principle study that uses longitudinal clinical data, including thyroid hormone levels from a large prospective study to define classes of TSH trajectories and examine changes in cardiovascular (CV) health markers over the study period. Methods: Growth mixture modeling (GMM), including latent class growth analysis (LCGA), was used to classify LT4-treated individuals participating in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) based on serial TSH levels. Repeated measure analyses were then utilized to assess within-class changes in blood pressure, lipid levels, hemoglobin A1c, and CV-related medication utilization. Results: From the 621 LT4-treated study participants, the best-fit GMM approach identified 4 TSH trajectory classes, as defined by their relationship to the normal TSH range: (1) high-high normal TSH, (2) normal TSH, (3) normal to low TSH, and (4) low to normal TSH. Notably, the average baseline LT4 dose was lowest in the high-high normal TSH group (77.7 mu g, P < .001). There were no significant differences in CV health markers between the classes at baseline. At least 1 significant difference in CV markers occurred in all classes, highlighted by the low to normal class, in which total and high-density lipoprotein cholesterol, triglycerides, and A1c all increased significantly (P = .049, P < .001, P < .001, and P = .001, respectively). Utilization of antihypertensive, antihyperlipidemic, and antidiabetes medications increased in all classes. Conclusion: GMM/LCGA represents a viable approach to define and examine LT4 treatment by TSH trajectory. More comprehensive datasets should allow for more complex trajectory modeling and analysis of clinical outcome differences between trajectory classes.
引用
收藏
页码:3065 / 3075
页数:11
相关论文
共 40 条
  • [1] Serum TSH and total T4 in the United States population and their association with participant characteristics:: National Health and Nutrition Examination Survey (NHANES 1999-2002)
    Aoki, Yutaka
    Belin, Ruth M.
    Clickner, Robert
    Jeffries, Rebecca
    Phillips, Linda
    Mahaffey, Kathryn R.
    [J]. THYROID, 2007, 17 (12) : 1211 - 1223
  • [2] Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): Objectives and Design
    Aquino, Estela M. L.
    Barreto, Sandhi Maria
    Bensenor, Isabela M.
    Carvalho, Marilia S.
    Chor, Dora
    Duncan, Bruce B.
    Lotufo, Paulo A.
    Mill, Jose Geraldo
    Molina, Maria Del Carmen
    Mota, Eduardo L. A.
    Azeredo Passos, Valeria Maria
    Schmidt, Maria Ines
    Szklo, Moyses
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 (04) : 315 - 324
  • [3] The association between TSH within the reference range and serum lipid concentrations in a population-based study.: The HUNT study
    Asvold, Bjorn O.
    Vatten, Lars J.
    Nilsen, Tom I. L.
    Bjoro, Trine
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (02) : 181 - 186
  • [4] Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range:: A population-based study
    Asvold, Bjorn O.
    Bjoro, Trine
    Nilsen, Tom I. L.
    Vatten, Lars J.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (03) : 841 - 845
  • [5] An Introduction to Latent Variable Mixture Modeling (Part 2): Longitudinal Latent Class Growth Analysis and Growth Mixture Models
    Berlin, Kristoffer S.
    Parra, Gilbert R.
    Williams, Natalie A.
    [J]. JOURNAL OF PEDIATRIC PSYCHOLOGY, 2014, 39 (02) : 188 - 203
  • [6] Levothyroxine Treatment Adequacy and Formulation Changes in Patients with Hypothyroidism: A Retrospective Study of Real-World Data from the United States
    Bianco, Antonio C.
    Bao, Yanjun
    Flores, Oscar Antunez
    Halpern, Rachel
    Le, Lisa
    Stackland, Sydnie
    Frieze, Todd
    [J]. THYROID, 2023, 33 (08) : 940 - 949
  • [7] Levothyroxine Use in the United States, 2008-2018
    Brito, Juan P.
    Ross, Joseph S.
    El Kawkgi, Omar M.
    Maraka, Spyridoula
    Deng, Yihong
    Shah, Nilay D.
    Lipska, Kasia J.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (10) : 1402 - 1405
  • [8] Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data
    Cai, Yunfei
    Ren, Yongkui
    Shi, Jingpu
    [J]. HYPERTENSION RESEARCH, 2011, 34 (10) : 1098 - 1105
  • [9] The Colorado thyroid disease prevalence study
    Canaris, GJ
    Manowitz, NR
    Mayor, G
    Ridgway, EC
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) : 526 - 534
  • [10] Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years
    Duncan, Meredith S.
    Vasan, Ramachandran S.
    Xanthakis, Vanessa
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (11):